Nanomolar propofol stimulates glutamate transmission to dopamine neurons: A possible mechanism of abuse potential?

Journal of Pharmacology and Experimental Therapeutics

Volumn 325, Issue 1, 2008, Pages 165-174

  Li, Ke Yong ^a   Xiao, Cheng ^a   Xiong, Ming ^a   Delphin, Ellise ^a   Ye, Jiang Hong ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; AMPA RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; GLUTAMIC ACID; PROPOFOL; RESERPINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG DEPENDENCE; EXCITATORY POSTSYNAPTIC POTENTIAL; MESENCEPHALON; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; NEURONS; PRESYNAPTIC TERMINALS; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D1; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTAL AREA;

EID: 41149110168     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.132472     Document Type: Article

References (39)

1. Adell A and Artigas F (2004) The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 28:415-431.
2. Alberto CO, Trask RB, Quinlan ME, and Hirasawa M (2006) Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons. J Neurosci 26:10043-10050.
3. Björklund A and Lindvall O (1975) Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res 83:531-537.
4. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, and Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. J Am Med Assoc 263:2055-2060.
5. Bormann J, Hamill OP, and Sakmann B (1987) Mechanism of anion permeation through channels gated by glycine and gamma-aminobutyric acid in mouse cultured spinal neurones. J Physiol 385:243-286.
6. Chait LD and Zacny JP (1992) Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans. Psychopharmacology (Berl) 107:255-262.
7. de Wit H, Uhlenhuth EH, and Johanson CE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16:341-360.
8. El-Ghundi M, George SR, Drago J, Fletcher PJ, Fan T, Nguyen T, Liu C, Sibley DR, Westphal H, and O'Dowd BF (1998) Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior. Eur J Pharmacol 353:149-158.
9. Gepts E, Claeys MA, Camu F, and Smekens L (1985) Infusion of propofol ('Diprivan') as sedative technique for colonoscopies. Postgrad Med J 61(Suppl 3):120-126.
10. Heinke W and Schwarzbauer C (2002) In vivo imaging of anaesthetic action in humans: approaches with positron emission tomography (PET) and functional magnetic resonance imaging (fMRI). Br J Anaesth 89:112-122.
11. Johnson SW and North RA (1992) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 450:455-468.
12. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18:75-113.
13. Kalivas PW and Duffy P (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem 56:961-967.
14. Kalivas PW and Duffy P (1995) D1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15:5379-5388.
15. Koga E and Momiyama T (2000) Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J Physiol 523:163-173.
16. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, and Harrison NL (1998) Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 53:530-538.
17. Lacey MG, Mercuri NB, and North RA (1990) Actions of cocaine on rat dopaminergic neurones in vitro. Br J Pharmacol 99:731-735.
18. LeSage MG, Stafford D, and Glowa JR (2000) Abuse liability of the anesthetic propofol: self-administration of propofol in rats under fixed-ratio schedules of drug delivery. Psychopharmacology (Berl) 153:148-154.
19. Liu X and Weiss F (2002) Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. J Pharmacol Exp Ther 300:882-889.
20. Lu XY, Churchill L, and Kalivas PW (1997) Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area. Synapse 25:205-214.
21. Margolis EB, Hjelmstad GO, Bonci A, and Fields HL (2003) Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23:9981-9986.
22. McAuliffe PF, Gold MS, Bajpai L, Merves ML, Frost-Pineda K, Pomm RM, Goldberger BA, Melker RJ, and Cendan JC (2006) Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses 66:874-882.
23. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445-1449.
24. Orser BA, McAdam LC, Roder S and MacDonald JF (1998) General anaesthetics and their effects on GABA(A) receptor desensitization. Toxicol Lett 100-101:217-224.
25. Pain L, Gobaille S, Schleef C, Aunis D and Oberling P (2002) In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg 95:915-919, table of contents.
26. Pain L, Oberling P, Sandner G, and Di Scala G (1996) Effect of propofol on affective state as assessed by place conditioning paradigm in rats. Anesthesiology 85:121-128.
27. Roussin A, Montastruc JL, and Lapeyre-Mestre M (2007) Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol 21:459-466.
28. Schulte D, Callado LF, Davidson C, Phillips PE, Roewer N, Schulte am Esch J, and Stamford JA (2000) Propofol decreases stimulated dopamine release in the rat nucleus accumbens by a mechanism independent of dopamine D2, GABAA and NMDA receptors. Br J Anaesth 84:250-253.
29. Shirasaka T, Yoshimura Y, Qiu DL, and Takasaki M (2004) The effects of propofol on hypothalamic paraventricular nucleus neurons in the rat. Anesth Analg 98:1017-1023.
30. Stern KN, Chait LD, and Johanson CE (1989) Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology (Berl) 98:81-88.
31. Takita A, Masui K, and Kazama T (2007) On-line monitoring of end-tidal propofol concentration in anesthetized patients. Anesthesiology 106:659-664.
32. Trantham-Davidson H, Neely LC, Lavin A, and Seamans JK (2004) Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24:10652-10659.
33. Uhlenhuth EH, Johanson CE, Kilgore K, and Kobasa SC (1981) Drug preference and mood in humans: preference for d-amphetamine and subject characteristics. Psychopharmacology (Berl) 74:191-194.
34. Weerts EM, Ator NA, and Griffiths RR (1999) Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug Alcohol Depend 57:51-60.
35. Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, Tran ZV, and Henthorn TK (2007) A survey of propofol abuse in academic anesthesia programs. Anesth Analg 105:1066-1071, table of contents.
36. Ye JH, Wang F, Krnjevic K, Wang W, Xiong ZG, and Zhang J (2004) Presynaptic glycine receptors on GABAergic terminals facilitate discharge of dopaminergic neurons in ventral tegmental area. J Neurosci 24:8961-8974.
37. Young AM HS (1986) Drugs as reinforcers: studies in laboratory animals, in Behavioral Analysis of Drug Dependence (Goldberg SR and Stolerman IP eds) pp 9-67, Academic Press, Orlando, FL.
38. Zacny JP, Lichtor JL, Thompson W, and Apfelbaum JL (1993a) Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesth Analg 77:544-552.
39. Zacny JP, Lichtor JL, Zaragoza JG, Coalson DW, Uitvlugt AM, Flemming DC, Binstock WB, Cutter T, and Apfelbaum JL (1993b) Assessing the behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. Drug Alcohol Depend 32:45-57.